The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2021
DOI: 10.1111/bcpt.13663
|View full text |Cite
|
Sign up to set email alerts
|

Antihistamine use during breastfeeding with focus on breast milk transfer and safety in humans: A systematic literature review

Abstract: Current data on use of antihistamines during breastfeeding and risks to the breastfed infant are insufficient. The aim of this systematic review was to provide an overview of studies measuring the levels of antihistamines in human breast milk, estimating the exposure for breastfed infants and/or reporting possible adverse effects on the breastfed infant. An additional aim was to review the antihistamine product labels available in the European Union (EU) and the United States. We searched seven online database… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 38 publications
0
12
1
Order By: Relevance
“…However, safety in pregnancy has been shown for cetirizine and loratadine only, and these drugs are therefore preferred 192,193 . The use of sgAHs such as loratadine and cetirizine is also advised in breastfeeding women 4 , as nursing infants can develop sedation from first-generation antihistamines secreted into breast milk 194 . Omalizumab is reported safe in pregnancy 115,[195][196][197][198] and in younger children, although current licensing is for individuals aged 12 years and older 146 .…”
Section: Treatment Of Special Populationsmentioning
confidence: 99%
“…However, safety in pregnancy has been shown for cetirizine and loratadine only, and these drugs are therefore preferred 192,193 . The use of sgAHs such as loratadine and cetirizine is also advised in breastfeeding women 4 , as nursing infants can develop sedation from first-generation antihistamines secreted into breast milk 194 . Omalizumab is reported safe in pregnancy 115,[195][196][197][198] and in younger children, although current licensing is for individuals aged 12 years and older 146 .…”
Section: Treatment Of Special Populationsmentioning
confidence: 99%
“…As UV absorbers, phenothiazine and many of its derivatives serve as electron donors for a range of CT systems. Conversely, certain phenothiazine derivatives, such as promethazine, chlorpromazine, and methotrimeprazine, exhibit biological activity as H 1 blockers, i.e., antihistamines, and have a clinical significance as antiemetic and antipsychotic medications. The antiviral properties of some of them raised quite an interest during the COVID-19 pandemic as potential agents against the SARS-CoV-2 virus. …”
Section: Resultsmentioning
confidence: 99%
“…This observation underlines the importance of having sufficient safety data available on the transfer of medicines to breastmilk. However, the available data on this subject are currently scarce [ 44 ], and for some medicines only consist of (single) case reports or case series with a limited number of included cases [ 45 ]. Hence, more attention for clinical lactation studies and non-clinical research methods to enhance our knowledge on this subject is also warranted [ 26 , 46 , 47 ].…”
Section: Discussionmentioning
confidence: 99%